246 related articles for article (PubMed ID: 31025500)
1. Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.
Lanna C; Cesaroni GM; Mazzilli S; Lozzi F; Palumbo V; Diluvio L; Bianchi L; Campione E
Dermatol Ther; 2019 Jul; 32(4):e12946. PubMed ID: 31025500
[TBL] [Abstract][Full Text] [Related]
2. Apremilast as a new treatment option for Acrodermatitis continua of Hallopeau.
Calleja Algarra A; Aragón Miguel R; Velasco Tamariz V; Prieto Barrios M; Andrés Lencina JJ; Vico Alonso C; Ortiz Romero PL; Rivera Díaz R
Australas J Dermatol; 2019 Aug; 60(3):e237-e238. PubMed ID: 30623424
[No Abstract] [Full Text] [Related]
3. Successful treatment of acrodermatitis continua of Hallopeau with apremilast.
Kurihara Y; Nakano K; Eto A; Furue M
J Dermatol; 2019 Oct; 46(10):e370-e371. PubMed ID: 31131903
[No Abstract] [Full Text] [Related]
4. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report.
Crowley EL; Maliyar K; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
SAGE Open Med Case Rep; 2019; 7():2050313X19829620. PubMed ID: 30800311
[TBL] [Abstract][Full Text] [Related]
5. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
[TBL] [Abstract][Full Text] [Related]
6. Two cases of acrodermatitis continua of Hallopeau associated with generalized arthritis.
Okuno H; Ogura K; Okuyama R; Itoi E
Acta Dermatovenerol Croat; 2013; 21(4):265-7. PubMed ID: 24476617
[TBL] [Abstract][Full Text] [Related]
7. Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients.
Piraccini BM; Fanti PA; Morelli R; Tosti A
Acta Derm Venereol; 1994 Jan; 74(1):65-7. PubMed ID: 7908489
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
Miller AC; Holland TE; Cohen DJ
J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
[TBL] [Abstract][Full Text] [Related]
9. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
Kazinski K; Joyce KM; Hodson D
J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
[TBL] [Abstract][Full Text] [Related]
10. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).
Rich P; Gooderham M; Bachelez H; Goncalves J; Day RM; Chen R; Crowley J
J Am Acad Dermatol; 2016 Jan; 74(1):134-42. PubMed ID: 26549249
[TBL] [Abstract][Full Text] [Related]
11. Real-world use of apremilast for patients with psoriasis in Japan.
Kishimoto M; Komine M; Hioki T; Kamiya K; Sugai J; Ohtsuki M
J Dermatol; 2018 Nov; 45(11):1345-1348. PubMed ID: 30168880
[TBL] [Abstract][Full Text] [Related]
12. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A
Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135
[No Abstract] [Full Text] [Related]
13. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
[TBL] [Abstract][Full Text] [Related]
14. Apremilast for the management of moderate to severe plaque psoriasis.
Vangipuram R; Alikhan A
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):349-360. PubMed ID: 28276777
[TBL] [Abstract][Full Text] [Related]
15. [Acrodermatitis continua of Hallopeau and psoriatic arthritis: A case report].
García C; Arellano J; Vera V; Corredoira Y
Medwave; 2020 Sep; 20(8):e8021. PubMed ID: 32956338
[TBL] [Abstract][Full Text] [Related]
16. Rapid improvement of nail matrix psoriasis with apremilast: clinical and ultrasonographic assessment.
Muñoz-Santos C; Sola-Ortigosa J; Guilabert A
Clin Exp Dermatol; 2018 Jul; 43(5):606-607. PubMed ID: 29453771
[No Abstract] [Full Text] [Related]
17. Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections.
Manfreda V; Esposito M; Campione E; Bianchi L; Giunta A
Postgrad Med; 2019 Apr; 131(3):239-240. PubMed ID: 30700196
[TBL] [Abstract][Full Text] [Related]
18. Acrodermatitis continua of Hallopeau (ACH): two cases successfully treated with adalimumab.
Di Costanzo L; Napolitano M; Patruno C; Cantelli M; Balato N
J Dermatolog Treat; 2014 Dec; 25(6):489-94. PubMed ID: 24215490
[TBL] [Abstract][Full Text] [Related]
19. Case of acrodermatitis continua accompanied by psoriatic arthritis.
Jo SJ; Park JY; Yoon HS; Youn JI
J Dermatol; 2006 Nov; 33(11):787-91. PubMed ID: 17073995
[TBL] [Abstract][Full Text] [Related]
20. Improvement of Nail and Scalp Psoriasis Using Apremilast in Patients With Chronic Psoriasis: Phase 2b and 3, 52-Week Randomized, Placebo-Controlled Trial Results.
Nguyen CM; Leon A; Danesh M; Beroukhim K; Wu JJ; Koo J
J Drugs Dermatol; 2016 Mar; 15(3):272-6. PubMed ID: 26954311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
